Abstract

The self-assembly phenomenon of amphiphiles has attracted particular attention in recent years due to its wide range of applications. The formation of nanoassemblies able to solubilize sparingly water-soluble drugs was found to be a strategy to solve the problem of poor solubility of active pharmaceutical ingredients. Binary and ternary solid dispersions containing Biopharmaceutics Classification System (BCS) class II drug bicalutamide and either Poloxamer®188 or Poloxamer®407 as the surface active agents were obtained by either spray drying or solvent evaporation under reduced pressure. Both processes led to morphological changes and a reduction of particle size, as confirmed by scanning electron microscopy and laser diffraction measurements. The increase in powder wettability was confirmed by means of contact angle measurements. The effect of an alteration of the crystal structure was followed by powder X-ray diffractometry while thermal properties were determined using differential scanning calorimetry. Interestingly, bicalutamide exhibited a polymorph transition after spray drying with the poloxamer and polyvinylpyrrolidone (PVP), while the poloxamer underwent partial amorphization. Moreover, due to the surface activity of the carrier, the solid dispersions formed nanoaggregates in water, as confirmed using dynamic light scattering measurements. The aggregates measuring 200–300 nm in diameter were able to solubilize bicalutamide inside the hydrophobic inner parts. The self-assembly of binary systems was found to improve the amount of dissolved bicalutamide by 4- to 8-fold in comparison to untreated drug. The improvement in drug dissolution was correlated with the solubilization of poorly soluble molecules by macromolecules, as assessed using emission spectroscopy.

Highlights

  • The issue of poor solubility of active pharmaceutical ingredients (APIs) is one of the biggest limitations for drug development

  • In the work reported we study the self-assembly phenomenon of solid dispersions containing either Poloxamer®188 or Poloxamer®407 and its effect on dissolution enhancement of the poorly water soluble drug bicalutamide (BCL)

  • Emission spectroscopy allowed for a correlation of the effect of dissolution changes with the solubilization related to the variations of molecular structure of used poloxamers

Read more

Summary

Introduction

The issue of poor solubility of active pharmaceutical ingredients (APIs) is one of the biggest limitations for drug development. Solid dispersions are commonly formed to enhance the water solubility of APIs; the number of marketed products arising from that strategy is rather low This is a result of the thermal instability of drug and carrier during preparation of systems, a poor in vitro–in vivo correlation, and instability during storage [15]. Among the strategies that allow for obtaining solid dispersions, solvent methods are often used In these techniques the drug and the carrier are dissolved in a volatile solvent such as ethanol [36] or Pharmaceutics 2019, 11, 130 methylene chloride–ethanol mixture [37] that is further evaporated. Poloxamers are the nonionic surfactants widely used in pharmaceutical formulations as emulsifiers, wetting agents and solubilizers They have been introduced into solid dispersions to enhance solubility and dissolution profiles of poorly water-soluble APIs from solid dosage forms [49,50]. Emission spectroscopy allowed for a correlation of the effect of dissolution changes with the solubilization related to the variations of molecular structure of used poloxamers

Materials
Methods of Preparation of Solid Dispersions
Laser Diffraction Measurements
Emission Spectroscopy
2.2.10. Contact Angle Determination
Solid State Characterization
Method Evaporation
Vibrational Spectroscopy
Wettability of Solid Dispersions
Dissolution Study
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call